التفاصيل البيبلوغرافية
| العنوان: |
Diseases of the Coronary Microcirculation: Diagnosis and Treatment. |
| المؤلفون: |
Ullrich-Daub, H., Daub, S., Olschewski, M., Münzel, T., Gori, T. |
| المصدر: |
Deutsches Ärzteblatt International; 11/3/2023, Vol. 120 Issue 44, p739-746, 8p |
| مستخلص: |
Background: Coronary microvascular dysfunction (CMD) comprises a variety of pathogenic mechanisms that impair the microcirculation of the heart. Clinical studies have shown that 3050% of patients suffering from myocardial ischemia without significant coronary artery stenosis have CMD. The disease is associated with elevated mortality and poor quality of life. Whenever a patient presents with symptoms of angina pectoris and no underlying disease is detected by the usual methods, CMD should be considered a possible cause. Methods: This review is based on publications retrieved by a selective search in PubMed and on current international guidelines and recommendations of specialty societies. Results: The diagnosis of CMD is based on objective evidence of a microvascular origin of symptoms. The guidelines contain a class I Ia recommendation for invasive coronary flow reserve and microvascular resistance measurements. Noninvasive tests such as positron emission tomography and cardiac magnetic resonance imaging are less accurate and are given a class I Ib recommendation. No high-quality therapeutic trials are available to date, and the treatment of CMD is thus based on that of chronic coronary syndrome. Lifestyle modification is performed to reduce risk factors. Patients with an abnormal coronary flow reserve or elevated microvascular resistance can be treated with an ACE inhibitor or angiotensin receptor blocker. Beta-blockers and calcium channel antagonists can relieve angina pectoris. Statins lower the LDL level and have positive pleiotropic effects. First-line treatment can be supplemented with further medications. Conclusion: Approximately 25% of patients with CMD have symptoms that do not respond to intensive treatment with the currently available modalities. New treatments, including interventional therapies, are being studied. Their long-term benefit remains to be assessed and compared to that of the existing methods. [ABSTRACT FROM AUTHOR] |
|
Copyright of Deutsches Ärzteblatt International is the property of Deutscher Aerzte-Verlag GmbH and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Supplemental Index |
